|
XmAb541 Clinical Trials
2 actively recruiting trials across 2 locations
▲ +1 trial since August 2026
Pipeline
Phase 1: 2
Top Sponsors
- Xencor, Inc.2
Indications
- Ovarian Cancer2
- Cancer2
- Ovarian Germ Cell Tumor1
- Testicular Germ Cell Tumor1
- Germ Cell Tumor1
Duarte, California1 trial
Phase 1
Lake Success, New York1 trial
Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors
Xencor Investigative Site
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.